Purpose: Rosacea is a common facial dermatosis, with flares induced by exposome factors. M89PF containing Vichy mineralizing water, probiotic fractions, hyaluronic acid, niacinamide and tocopherol repairs the skin barrier and reinforces skin defences against exposome factors. This study assessed the benefit of M89PF in subjects with rosacea associated with erythema and sensitive skin during the Covid-19 pandemic using protective face masks.
Methods: M89PF was compared to usual skin care in a randomized, split-face study, for 30 days in subjects with rosacea associated with erythema and sensitive skin. Clinical evaluations included erythema, desquamation, skin tightness, dryness, burning sensation, itching, stinging, stinging test, and local tolerability. Instrument evaluations included erythema, skin hydration and TEWL. Subject satisfaction was also assessed.
Results: Erythema significantly improved with M89PF at both time points (p<0.01 at D15, and p<0.001 at D30). Skin sensitivity assessed by the skin stinging test improved significantly (p<0.01) with M89PF at D30, compared to baseline and usual skin care. Skin erythema, tightness, dryness, hydration and TEWL significantly improved (p≤0.05) with M89PF at D15 and D30, versus baseline and the untreated side. Subjects were highly satisfied with M89PF at D15 and D30. Tolerance was very good in all subjects.
Conclusion: In subjects with rosacea, M89PF significantly reduces erythema, skin tightness, dryness and TEWL, and improves skin hydration and skin sensitivity, even when using protective masks. M89PF is well tolerated and received high satisfaction ratings.
Clinicaltrialsgov No: NCT05562661.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843703 | PMC |
| http://dx.doi.org/10.2147/CCID.S391893 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Resolution of Treatment-Refractory Papulopustular Rosacea With Combined Light Source Photodynamic Therapy Using Pre-incubation Nonablative Fractionated Laser Resurfacing.
Cureus
November 2024
Dermatology, University of California, San Diego, USA.
Papulopustular rosacea is an inflammatory subtype of rosacea that can significantly impair patients' quality of life. Available treatment options range from anti-inflammatory topical and oral medications to laser and light therapies. Photodynamic therapy with aminolevulinic acid (ALA-PDT) has emerged as a more recent treatment option for papulopustular rosacea.
View Article and Find Full Text PDFEvaluation of Helicobacter pylori and Small Intestinal Bacterial Overgrowth in Subjects With Rosacea.
Cureus
October 2024
Dermatology, University of Michigan, Ann Arbor, USA.
Article Synopsis
- Systemic immune system abnormalities may play a role in rosacea development, with studies indicating a higher presence of abnormal bacteria and small intestinal bacterial overgrowth (SIBO) in affected individuals, though inconsistent testing has led to discrepancies in findings.* -
- This study aimed to accurately assess the prevalence of abnormal bacteria and SIBO in individuals with rosacea while controlling for potential confounding factors, excluding those with gastrointestinal diseases or significant health issues.* -
- Findings showed that 14.8% tested positive for abnormal bacteria and 33.3% for SIBO, with a notably higher SIBO rate in the rosacea cohort compared to the general population, suggesting a possible link between SIBO and ros
Efficacy and Safety of Microencapsulated Benzoyl Peroxide Cream, 5%, in Papulopustular Rosacea in Elderly Patients: Post-hoc Analysis of Results from Two Randomized, Phase III, Vehicle-controlled Trials.
J Clin Aesthet Dermatol
October 2024
Dr. Werschler is with Spokane Dermatology Clinic and Werschler Aesthetics in Spokane, Washington.
Objective: We sought to compare the efficacy and safety of encapsulated benzoyl peroxide (E-BPO) cream, 5%, versus vehicle in subjects <65 years of age versus subjects ≥65 with moderate to severe papulopustular rosacea.
Methods: This analysis used pooled results from two 12-week, randomized, vehicle-controlled Phase III trials (NCT03564119, NCT03448939) of E-BPO cream, 5%. These trials included 733 subjects randomized 2:1 to E-BPO or vehicle.
Scalp Rosacea Treated with Topical Ivermectin.
Skin Appendage Disord
October 2024
Dermatology Clinic, University of Catania, Catania, Italy.
Article Synopsis
- Scalp rosacea is frequently misdiagnosed and lacks approved treatments, making it a challenge for healthcare professionals.
- A case study of 5 adults with scalp rosacea showed positive results using ivermectin 1% cream applied daily for 12 weeks.
- The findings indicate that assessing the scalp during rosacea evaluations is important and suggest that ivermectin may be an effective treatment option for scalp rosacea.
Article Synopsis
- Cleansing is crucial for preventing infections, but it can be tricky for those with skin conditions since traditional cleansers might damage the skin barrier while removing dirt and oils.
- This study assessed a new foaming gel cleanser made with polymeric surfactant technology on 85 individuals with sensitive skin for four weeks.
- Results indicated significant improvements in skin comfort and appearance without irritation, suggesting this cleanser is effective and gentle for sensitive skin types.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!